✦ LIBER ✦

PSY34 COST-EFFECTIVENESS OF TAPENTADOL PROLONGED-RELEASE (PR) COMPARED TO OXYCODONE AND MORPHINE IN PATIENTS WITH CHRONIC MODERATE TO SEVERE NON-CANCER PAIN IN SWEDEN

✍ Scribed by Hertel, N; Ikenberg, R; Fricke, FU; Liedgens, H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PSY31 Cost-Effectiveness of Tapentadol P

✍ M. Obradovic; R. Ikenberg; N. Hertel; H. Liedgens 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Quality of life benefits and cost impact

✍ Dunlop, William; Uhl, Reiner; Khan, Iftekhar; Taylor, Anna; Barton, Garry 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 504 KB

Analgesic Efficacy and Safety of Oxycodo

✍ Dana Vondrackova; Petra Leyendecker; Winfried Meissner; Michael Hopp; Istvan Szo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 608 KB

Quality of Life Benefits and Cost Impact

✍ Dunlop, W.; Neufeld, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

The concordance of patient and physician

✍ E. Ross; A. Weil; J. Sasaki; B. Nicholson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Sustained Safety and Efficacy of Once-Da

✍ Ute Richarz; Sandra Waechter; Rainer Sabatowski; Leszek Szczepanski; Heinrich Bi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB